CLINICAL CARDIOLOGICAL PREDICTORS IN THE COVID-19 PANDEMIC: AN INTEGRATIVE REVIEW

Abstract

Introduction: COVID-19, caused by severe acute respiratory syndrome (SARS-Cov-2), started in China, in Hubei province, triggering a pandemic. Prognostic factors or clinical predictors are characteristics that can be used to predict the progression of the disease and how chronic comorbidities can influence the poor prognosis of patients who have them and are infected by the new coronavirus. Objective: To analyze the clinical predictors in the literature in patients with heart disease infected by COVID-19. Method: This is an integrative literature review study. To elaborate the guiding question, the method used was the PVO strategy where P (population) is the heart disease patients infected by COVID-19, the V (variable) is the variable of interest, which, in this study they will be the clinical predictors during the infection and finally the O (outcome) consists of the results, that is, the prognosis and clinical manifestations. The research was carried out in the Virtual Health Library (VHL) and in PubMed. Results: The initial search resulted in 228 articles and using the PRISMA tool, 37 articles were selected for the partial sample. The final sample consisted of 27 original articles published in English, Spanish and Portuguese. The selected publications were subjected to thematic analysis, separated and grouped into five categories: laboratory alterations, imaging tests, continuous use medications, comorbidities and electrocardiographic alterations. Conclusion: The relationship between the cardiovascular system and the Coronavirus infection is evident in several studies and it is evident that this association leads to more serious outcomes for patients.